Next Generation News and Research

RSS

Study reveals key mechanisms behind cancer cells adapting to extra chromosomes

Cancer cells have special adaptation mechanisms that allow them to proliferate despite changes in their genetic makeup.

13 Feb 2025

Yourgene Health launches IONA Care+ non-invasive prenatal testing service

Yourgene Health (part of the Novacyt group of companies), a leading international molecular diagnostics group, today announced the launch of IONA® Care+, a fully comprehensive non-invasive prenatal screening service for genetic conditions, in the UK.

13 Feb 2025

Cubic receives European patent for medical ultrasonic gas sensor

The patented V-shaped ultrasonic gas sensor technology by Cubic offers advanced measurement solutions, enhancing reliability in critical healthcare equipment.

From Cubic Sensor and Instrument Co. Ltd 13 Feb 2025

TG Therapeutics to use MaxCyte's Flow Electroporation® technology and ExPERT™ platform

MaxCyte, Inc., a leading, cell-engineering focused company providing enabling platform technologies to advance the discovery, development and commercialization of next-generation cell-based therapeutics, today announced they are entering into a strategic platform license (SPL) with TG Therapeutics, a fully integrated, commercial stage, biopharmaceutical company focused on the acquisition, development and commercialization of novel treatments for B-cell diseases.

From MaxCyte, Inc. 13 Feb 2025

Special zinc-based dissolvable material could transform treatment of broken bones

Monash research could transform how broken bones are treated, with the development of a special zinc-based dissolvable material that could replace the metal plates and screws typically used to hold fractured bones together.

12 Feb 2025

New light-sensitive chemicals show promise for treating aggressive breast cancers

Scientists have developed new light-sensitive chemicals that can radically improve the treatment of aggressive cancers with minimal side effects.

11 Feb 2025

Insilico Medicine announces preclinical drug discovery benchmarks from 2021 to 2024

Insilico Medicine ( "Insilico") , a clinical stage generative artificial intelligence (AI)-driven biotechnology company today announced a set of preclinical drug discovery benchmarks from the 22 developmental candidate nominations achieved by its platform from 2021 to 2024.

11 Feb 2025

AZoNetwork honors women in STEM on the 10th anniversary of IDWGS

AZoNetwork is joining the global effort to close the gender gap.

11 Feb 2025

Groundbreaking advances in tuberculosis vaccine development and therapies

Despite decades of efforts, tuberculosis remains a global health crisis, claiming over 1.3 million lives annually.

10 Feb 2025

Study assesses perceptions and barriers to integrated care training and practice

Integrated care – a coordinated approach that addresses patients' physical, mental and social health needs – has been shown to improve patient outcomes, reduce health care costs and address health disparities.

10 Feb 2025

Tick-borne encephalitis emerges in Britain: Experts urge vigilance

Tick-borne encephalitis virus (TBEV) has now been confirmed in locally acquired human cases in the U.K., with evidence of established transmission in British tick populations. Increased surveillance and clinician awareness are crucial to detecting and managing this emerging threat.

10 Feb 2025

University of Oulu advances biosensor technology for disease detection

The University of Oulu is at the forefront of developing cutting-edge biosensor technology that could revolutionize the early diagnosis and treatment of diseases.

10 Feb 2025

Modifying biomaterials may lead to more effective cancer therapies

Modifying the physical characteristics of microscopic biomaterials to interact seamlessly with the body's tissues could unlock safer and more effective cancer treatments, according to Virginia Tech researchers at the Fralin Biomedical Research Institute at VTC.

7 Feb 2025

UConn receives $400,000 grant for cutting-edge autism research

Just in time for the Super Bowl, researchers at UConn School of Medicine are part of a big win for autism research.

7 Feb 2025

AI-based technology accelerates discovery of new tuberculosis drug candidates

Tuberculosis is a serious global health threat that infected more than 10 million people in 2022. Spread through the air and into the lungs, the pathogen that causes "TB" can lead to chronic cough, chest pains, fatigue, fever and weight loss.

7 Feb 2025

RUFY1-RET fusion identified as mechanism of resistance to lorlatinib in lung cancer

A new case report was published in Volume 16 of Oncotarget on February 5, 2025, titled "Acquired RUFY1-RET rearrangement as a mechanism of resistance to lorlatinib in a patient with CD74-ROS1 rearranged non-small cell lung cancer: A case report."

6 Feb 2025

Advancing living materials with precise control over mechanical properties

Rice University researchers have revealed novel sequence-structure-property relationships for customizing engineered living materials (ELMs), enabling more precise control over their structure and how they respond to deformation forces like stretching or compression.

6 Feb 2025

MaxCyte® acquires SeQure Dx to broaden cell engineering offerings with on-target and off-target editing assessments

MaxCyte, Inc., a leading, cell-engineering focused company providing solutions to advance the discovery, development and commercialization of next-generation cell therapeutics announced today the acquisition of SeQure Dx, a market leader of on-target and off-target editing assessment services for cell and gene therapies.

From MaxCyte, Inc. 6 Feb 2025

New nasal vaccine for COVID-19 set to begin clinical trial in the U.S.

A nasal vaccine for COVID-19 – based on technology developed at Washington University in St. Louis – is poised to enter a phase 1 clinical trial in the U.S. after an investigational new drug application from Ocugen, Inc. was approved by the Food and Drug Administration (FDA). Ocugen, a U.S.-based biotechnology company, licensed the innovative technology from WashU in 2022.

5 Feb 2025

Inhibiting S6K2 gene offers potential treatment for drug-resistant melanoma

The lab of The Wistar Institute's Jessie Villanueva, Ph.D., has identified a new strategy for attacking treatment-resistant melanoma: inhibiting the gene S6K2. .

5 Feb 2025

Next Generation News and Research

Study reveals key mechanisms behind cancer cells adapting to extra chromosomes

Yourgene Health launches IONA Care+ non-invasive prenatal testing service

Cubic receives European patent for medical ultrasonic gas sensor

TG Therapeutics to use MaxCyte's Flow Electroporation® technology and ExPERT™ platform

Special zinc-based dissolvable material could transform treatment of broken bones

New light-sensitive chemicals show promise for treating aggressive breast cancers

Insilico Medicine announces preclinical drug discovery benchmarks from 2021 to 2024

AZoNetwork honors women in STEM on the 10th anniversary of IDWGS

Groundbreaking advances in tuberculosis vaccine development and therapies

Study assesses perceptions and barriers to integrated care training and practice

Tick-borne encephalitis emerges in Britain: Experts urge vigilance

University of Oulu advances biosensor technology for disease detection

Modifying biomaterials may lead to more effective cancer therapies

UConn receives $400,000 grant for cutting-edge autism research

AI-based technology accelerates discovery of new tuberculosis drug candidates

RUFY1-RET fusion identified as mechanism of resistance to lorlatinib in lung cancer

Advancing living materials with precise control over mechanical properties

MaxCyte® acquires SeQure Dx to broaden cell engineering offerings with on-target and off-target editing assessments

New nasal vaccine for COVID-19 set to begin clinical trial in the U.S.

Inhibiting S6K2 gene offers potential treatment for drug-resistant melanoma

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

How Omics Technologies Are Transforming Biological Research and Drug Discovery

Latest News